Beverley SM - Search Results

1

Study of the safety, immunogenicity and efficacy of attenuated and killed Leishmania (Leishmania) major vaccines in a rhesus monkey (Macaca mulatta) model of the human disease.

Amaral VF, Teva A, Oliveira-Neto MP, Silva AJ, Pereira MS, Cupolillo E, Porrozzi R, Coutinho SG, Pirmez C, Beverley SM, Grimaldi G Jr. Amaral VF, et al. Among authors: beverley sm. Mem Inst Oswaldo Cruz. 2002 Oct;97(7):1041-8. doi: 10.1590/s0074-02762002000700019. Mem Inst Oswaldo Cruz. 2002. PMID: 12471434 Free article.

2

A dhfr-ts- Leishmania major knockout mutant cross-protects against Leishmania amazonensis.

Veras P, Brodskyn C, Balestieri F, Freitas Ld, Ramos A, Queiroz A, Barral A, Beverley S, Barral-Netto M. Veras P, et al. Mem Inst Oswaldo Cruz. 1999 Jul-Aug;94(4):491-6. doi: 10.1590/s0074-02761999000400011. Mem Inst Oswaldo Cruz. 1999. PMID: 10446007 Free article.

3

Intergenic region typing (IRT): a rapid molecular approach to the characterization and evolution of Leishmania.

Cupolillo E, Grimaldi Júnior G, Momen H, Beverley SM. Cupolillo E, et al. Among authors: beverley sm. Mol Biochem Parasitol. 1995 Jul;73(1-2):145-55. doi: 10.1016/0166-6851(95)00108-d. Mol Biochem Parasitol. 1995. PMID: 8577322

4

Virulent or avirulent (dhfr-ts-) Leishmania major elicit predominantly a type-1 cytokine response by human cells in vitro.

Brodskyn C, Beverley SM, Titus RG. Brodskyn C, et al. Among authors: beverley sm. Clin Exp Immunol. 2000 Feb;119(2):299-304. doi: 10.1046/j.1365-2249.2000.01122.x. Clin Exp Immunol. 2000. PMID: 10632666 Free PMC article.

5

Immunization with persistent attenuated Delta lpg2 Leishmania major parasites requires adjuvant to provide protective immunity in C57BL/6 mice.

Kébaïer C, Uzonna JE, Beverley SM, Scott P. Kébaïer C, et al. Among authors: beverley sm. Infect Immun. 2006 Jan;74(1):777-80. doi: 10.1128/IAI.74.1.777-780.2006. Infect Immun. 2006. PMID: 16369039 Free PMC article.

6

Naturally-occurring gene amplifications conferring drug resistance in Leishmania tarentolae.

Beverley SM, Petrillo-Peixoto M. Beverley SM, et al. Mem Inst Oswaldo Cruz. 1988 Nov;83 Suppl 1:330-3. doi: 10.1590/s0074-02761988000500017. Mem Inst Oswaldo Cruz. 1988. PMID: 3253502 Free article. No abstract available.

7

Priming of a beta-galactosidase (beta-GAL)-specific type 1 response in BALB/c mice infected with beta-GAL-transfected Leishmania major.

Chakkalath HR, Siddiqui AA, Shankar AH, Dobson DE, Beverley SM, Titus RG. Chakkalath HR, et al. Among authors: beverley sm. Infect Immun. 2000 Feb;68(2):809-14. doi: 10.1128/IAI.68.2.809-814.2000. Infect Immun. 2000. PMID: 10639450 Free PMC article.

8

Vaccination with phosphoglycan-deficient Leishmania major protects highly susceptible mice from virulent challenge without inducing a strong Th1 response.

Uzonna JE, Späth GF, Beverley SM, Scott P. Uzonna JE, et al. Among authors: beverley sm. J Immunol. 2004 Mar 15;172(6):3793-7. doi: 10.4049/jimmunol.172.6.3793. J Immunol. 2004. PMID: 15004184

9

Development of a safe live Leishmania vaccine line by gene replacement.

Titus RG, Gueiros-Filho FJ, de Freitas LA, Beverley SM. Titus RG, et al. Among authors: beverley sm. Proc Natl Acad Sci U S A. 1995 Oct 24;92(22):10267-71. doi: 10.1073/pnas.92.22.10267. Proc Natl Acad Sci U S A. 1995. PMID: 7479765 Free PMC article.

10

Inoculation of killed Leishmania major into immune mice rapidly disrupts immunity to a secondary challenge via IL-10-mediated process.

Okwor I, Liu D, Beverley SM, Uzonna JE. Okwor I, et al. Among authors: beverley sm. Proc Natl Acad Sci U S A. 2009 Aug 18;106(33):13951-6. doi: 10.1073/pnas.0905184106. Epub 2009 Aug 6. Proc Natl Acad Sci U S A. 2009. PMID: 19666482 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

273 results

Search Page